Development of a Novel Clinical Trial Design to Evaluate the Effects of Joint Therapeutics on Cartilage Turnover in Healthy Subjects
therapeutic interventions. Of these biomarkers, c-terminal Cross- Linked Telopeptide of type-II collagen (CTX-II), a marker of cartilage degradation, has shown the most potential. The purpose of this ... increased…

